Ca supplement in deficiency states; adjunct in the management of osteoporosis; antacid; treatment of hyperphosphatemia in patients w/ chronic renal failure or associated secondary hyperparathyroidism.
Up to 1.5 g. Hyperphosphatemia in patients w/ chronic renal failure Initially 2.5 g daily in divided doses, may be increased up to 17 g daily in divided doses as required. Childn 12-18 yr 1.25 g, 6-12 yr 600 mg, 1-6 yr 300 mg. Infant 1 mth-1 yr 120 mg. Doses to be given tid-qid.
Hyperkalemia in patients w/ renal impairment or after taking high doses. Alkalosis may occur. Rarely, milk-alkali syndrome & tissue calcification may occur.
A02AC01 - calcium carbonate ; Belongs to the class of calcium-containing antacids. A12AA04 - calcium carbonate ; Belongs to the class of calcium-containing preparations. Used as dietary supplements.
Sign Out
